0001209191-20-024640.txt : 20200416
0001209191-20-024640.hdr.sgml : 20200416
20200416160916
ACCESSION NUMBER: 0001209191-20-024640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200414
FILED AS OF DATE: 20200416
DATE AS OF CHANGE: 20200416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Winter Gregory Paul
CENTRAL INDEX KEY: 0001777021
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 20796494
MAIL ADDRESS:
STREET 1: /O BICYCLE THERAPEUTICS LIMITED
STREET 2: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB222 3AT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-14
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001777021
Winter Gregory Paul
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
1
0
0
0
Ordinary Shares
2020-04-14
4
M
0
71450
A
163927
D
Series A Preferred Shares Warrant
2020-04-14
4
M
0
71450
0.00
D
Ordinary Shares
71450
71450
D
The Warrants to purchase Series A Preferred Shares had an exercise price of a nominal value per Series A Preferred Share, and, following Bicycle Therapeutics plc's initial public offering, became exercisable for ordinary shares. The Warrants are immediately exercisable and expire on May 26, 2027.
/s/ Lee Kalowski, Attorney-in-Fact
2020-04-16